Drreddys Laboratories | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
ANI Pharmaceuticals USD 76.53M 6.81M 2025-03
Aurora Cannabis CAD 38.18M 2.05M 2024-12
Bayer EUR 3.71B 628M 2025-03
Canopy Growth CAD 40.62M 308K 2024-12
Cipla INR 12.33B 354.8M 2025-03
Corcept Therapeutics USD 90.66M 7.29M 2025-03
Drreddys Laboratories INR 21.59B 436M 2024-12
GlaxoSmithKline GBP 2.06B 603M 2025-03
Hikma Pharmaceutical USD 280M 4M 2024-06
Novartis USD 3.5B 368M 2024-12
Pacira USD 86.78M 7.16M 2025-03
Prestige Brands USD 64.05M 73K 2025-03
Richter Gedeon HUF 51.12B 4.36B 2024-09
Sun Pharmaceuticals INR 25.52B 745.8M 2024-12
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
Teva Pharmaceutical Industries USD 919M 33M 2025-03



Drreddys Laboratories Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.